Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 49,640 |
|
|||||
| News | (1) | ||||||
| Day High | 5.00 | Low High |
|||||
| Day Low | 4.41 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.2435 | 5.69% | 4.5235 | 19:06:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.49 | 4.41 | 5.00 | 4.5235 | 4.28 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 733 | 49,640 | $ 4.59 | $ 227,738 | - | 4.28 - 24.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:06:10 | 1 | $ 4.44 | USD |
Moleculin Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 151.03M | 33.41M | - | 0 | -29.77M | -0.89 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.06 | 5.1299 | 4.28 | 4.54 | 18,443 | -0.5365 | -10.60% |
| 1 Month | 6.105 | 7.3485 | 4.28 | 5.66 | 118,608 | -1.58 | -25.90% |
| 3 Months | 7.65 | 10.35 | 4.28 | 7.22 | 121,041 | -3.13 | -40.87% |
| 6 Months | 10.5615 | 15.75 | 4.28 | 8.63 | 155,637 | -6.04 | -57.17% |
| 1 Year | 14.25 | 24.75 | 4.28 | 9.68 | 194,107 | -9.73 | -68.26% |
| 3 Years | 50.85 | 59.85 | 4.28 | 25.34 | 166,424 | -46.33 | -91.10% |
| 5 Years | 16.20 | 131.70 | 4.28 | 26.46 | 1,034,420 | -11.68 | -72.08% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. |
